DHR
Danaher Corporation
Diagnostics & Research · Healthcare · United States
203.89
close · 2026-08-13
value
60
cheaper than peers60
quality
51
stronger fundamentals51
ranked against
Diagnostics & Research
value
quality
28 peers
Value inputs
| measure | company | vs peers |
| price to book | 2.73× | 71 |
| EV to EBITDA | 20.14× | 62 |
| forward P/E | 21.93× | 61 |
| price to sales | 5.57× | 43 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 19.8% | 80 |
| return on equity | 7.6% | 56 |
| debt to equity | 53.0% | 52 |
| revenue growth | 5.5% | 20 |
4 of 4 measures available
Facts
| market cap | $143B |
| free cash flow | $4.33B |
| employees | 58,000 |
| first trade | 1978-12-29 |
| next earnings | 2026-07-21 |
| fundamentals updated | 2026-07-28 |